| Net income (loss) | -672.68K |
| Depreciation and amortization | |
| Loss on sale of discontinued operations | |
| Stock compensation expense | 432.61K |
| Deferred income taxes | -434.33K |
| Provision for (recovery of) losses on accounts receivable | |
| Accounts receivable | -176.02K |
| Inventories | -1.6M |
| Prepaid expenses and other assets | -14.16K |
| Accounts payable, accrued expenses and other current liabilities | |
| Net cash (used for) operating activities | -742.41K |
| Capital expenditures | -715.13K |
| Proceeds from disposition of Willtek assets - net | |
| Net cash provided by (used for) investing activities | |
| Payments of mortgage note | |
| Payment of bank note | |
| Acquisition of treasury stock - 701,417 shares | -65.47K |
| Net cash (used for) financing activities | -166.76K |
| Effect of foreign currency on cash and cash equivalents | |
| NET (DECREASE) IN CASH AND CASH EQUIVALENTS | -1.62M |
| Cash and cash equivalents, at beginning of period | 9.73M |
| CASH AND CASH EQUIVALENTS, AT END OF PERIOD | 8.1M |
| Taxes | 67.44K |
| Interest | |